Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-18

FDA Approved: SAPROPTERIN DIHYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original application for sapropterin dihydrochloride, a generic version of the PKU therapy. This action expands access to t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sapropterin dihydrochloride (Sapropterin dihydrochloride)

Snippet

ORIG AP for SAPROPTERIN DIHYDROCHLORIDE (SAPROPTERIN DIHYDROCHLORIDE)